Literature DB >> 30985453

Presepsin As a Biomarker for Evaluating Prognosis and Early Innate Immune Response of Out-of-Hospital Cardiac Arrest Patients After Return of Spontaneous Circulation.

Zhijiang Qi1, Qiang Zhang, Bo Liu, Fei Shao, Chunsheng Li.   

Abstract

OBJECTIVES: After return of spontaneous circulation, patients who experienced out-of-hospital cardiac arrest present an impaired innate immune response that resembles sepsis. Presepsin, a new biomarker for sepsis, has not been studied in out-of-hospital cardiac arrest patients. This study explored the role of presepsin in evaluating the prognosis and early innate immune alteration of out-of-hospital cardiac arrest patients after return of spontaneous circulation by observing presepsin levels, CD14, and human leukocyte antigen-DR expression on monocytes.
DESIGN: Retrospective analysis.
SETTING: The emergency department of an urban university tertiary hospital. PARTICIPANTS: One hundred sixty-five out-of-hospital cardiac arrest patients with return of spontaneous circulation more than 12 hours, and 100 healthy individuals.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Plasma presepsin and procalcitonin levels were tested after resuscitation (day 0) and on days 1 and 3 after return of spontaneous circulation. Presepsin levels were higher in out-of-hospital cardiac arrest patients than in healthy individuals. In the first 3 days, presepsin and procalcitonin levels were persistently lower in 28-day survivors and patients with favorable neurologic outcome patients than in 28-day nonsurvivors and patients with unfavorable neurologic outcome. On days 0, 1, and 3, different cut-off values of presepsin showed prognostic value for 28-day mortality and favorable neurologic outcomes similar to procalcitonin. CD14 and human leukocyte antigen-DR expression on monocytes were analyzed by flow cytometry. Compared with controls, CD14 expression in out-of-hospital cardiac arrest patients increased on day 1 and began to decrease on day 3, whereas human leukocyte antigen-DR+ monocyte percentages decreased on days 1 and 3. Presepsin and procalcitonin had a low positive correlation with CD14 expression and a strong negative correlation with human leukocyte antigen-DR+ monocyte percentages on day 1.
CONCLUSIONS: Plasma presepsin concentrations are independent prognostic factors for out-of-hospital cardiac arrest patients after return of spontaneous circulation and are correlated with abnormal CD14 and human leukocyte antigen-DR expression on monocytes. Monitoring presepsin levels may be helpful for evaluating the prognosis and impaired innate immune response in the early period after return of spontaneous circulation.

Entities:  

Year:  2019        PMID: 30985453     DOI: 10.1097/CCM.0000000000003764

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Identification and Validation of Novel Potential Pathogenesis and Biomarkers to Predict the Neurological Outcome after Cardiac Arrest.

Authors:  Qiang Zhang; Chenyu Zhang; Cong Liu; Haohong Zhan; Bo Li; Yuanzhen Lu; Hongyan Wei; Jingge Cheng; Shuhao Li; Chuyue Wang; Chunlin Hu; Xiaoxing Liao
Journal:  Brain Sci       Date:  2022-07-15

2.  Dynamic blood presepsin levels are associated with severity and outcome of acute pancreatitis: A prospective cohort study.

Authors:  Hong-Li Xiao; Guo-Xing Wang; Yan Wang; Zhi-Min Tan; Jie Zhou; Han Yu; Miao-Rong Xie; Chun-Sheng Li
Journal:  World J Gastroenterol       Date:  2022-09-21       Impact factor: 5.374

3.  Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation.

Authors:  Katrin Fink; Sebastian Grundmann; Alexander Asmussen; Hans-Jörg Busch; Thomas Helbing; Xavier Bemtgen; Christian Smolka; Christoph Bode
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

4.  Evaluation of the Diagnostic and Prognostic Value of CSF Presepsin Levels in Patients with Postneurosurgical Ventriculitis/Meningitis.

Authors:  Guanghui Zheng; Chenxi Zhang; Guojun Zhang; Chunqing Shao
Journal:  Infect Drug Resist       Date:  2021-07-27       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.